Prior Auth Required
92130 - 2 Filspari (sparsentan) prescribing information. Travere Therapeutics, Inc., San Diego, CA 8/2025 2/2026
This procedure appears on the selected insurer prior authorization source.
Prior authorizationPrior Auth Required
Procedure / Service2 Filspari (sparsentan) prescribing information. Travere Therapeutics, Inc., San Diego, CA 8/2025 2/2026
Procedure / Service Description
Updated Accessed - Updated Accessed 1 National Organization for Rare Disorders (NORD®). Available at https://rarediseases.org/ 2/2026 2 Filspari (sparsentan) prescribing information. Travere Therapeutics, Inc., San Diego, CA 92130 8/2025 2/2026 3 Uplizna (inebilizumab-cdon) prescribing information, Viela Bio, In., Gaithersburg, MD 20878 12/2025 2/2026 4 Vanrafia (atrasentan) prescribing information. Novartis Pharmaceuticals Corporation East Hanover, New 4/2025 2/2026
Likely documents
- Confirm benefit details
- Submit clinical notes if requested by the plan
Next actions
- Confirm the current plan policy before submission.
- Use the insurer authorization workflow for this listed code.